GlassScriptPhysician profile
Thomas M Jetmore
NPI 1104274463
$3,913.37
in general payments reported to CMS, 2019-2025
7 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $768 · 2023: $348 · 2024: $1,473 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,711 · Travel and Lodging: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,711.12 |
| Travel and Lodging | $1,299.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,675.59 | 2021-2025 | Scopis Ent, Xpress Ent Dilation System, Xpress Loprofile |
| Smith+Nephew, INC. | $1,100.10 | 2021-2024 | Coblation, Tula, Rf20000 |
| Inspire Medical Systems, INC. | $955.72 | 2023-2025 | Inspire |
| Aerin Medical INC. | $112.24 | 2022 | |
| Optinose US, INC. | $37.36 | 2021 | |
| Genzyme Corporation | $17.12 | 2022 | |
| Agiliti Surgical, INC. | $15.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Jetmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.